Increasing patient engagement in clinical trials offers opportunities to improve enrollment and retention in clinical trials, helping ensure interventions can be evaluated effectively and that clinical research dollars are used efficiently. Patient and provider awareness, trial exclusion criteria, proximity to trial sites, out-of-pocket medical expenses, and other factors all present as barriers to patient engagement in clinical trials. Congressional and Departmental action has made progress on reducing barriers to trial participation, but there are additional opportunities for future policy action to further empower patient participation.
*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to Allison Kolbe, Allison.Kolbe@hhs.gov. Content will be updated pending the outcome of the Section 508 review.